# Rafarm S.A. – FDA Inspection, Oct 17, 2017

Source: https://www.keypedia.com/records/fda_inspections/rafarm-sa/ebf080e1-9f3e-490d-bf48-8b531b95a96d
Source feed: FDA_Inspections

> FDA inspection 1030183 of Rafarm S.A., October 17, 2017. Classification: Voluntary Action Indicated (VAI). 5 citations under 21 CFR part 211. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1030183
- Company Name: Rafarm S.A.
- Inspection Date: 2017-10-17
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Generic Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 5

## Related Documents

- FDA Inspection 1300434 - 2024-06-21
- [FDA Inspection 1225663 - 2023-05-19](https://www.keypedia.com/records/fda_inspections/rafarm-sa/b8f780cb-150f-479c-972b-49798ad3c1d3)
- FDA Inspection 1155967 - 2021-06-04
- FDA Inspection 1123693 - 2020-03-11
- FDA Inspection 1101881 - 2019-07-30

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/junho-pak/4abe53fb-ad20-490d-9e71-6216a9f863f5)

Company: https://www.keypedia.com/companies/rafarm-sa/147e9812-6247-4b31-82b4-c444b23955ce

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8